Dipexium Pharmaceuticals Inc. Appears in The Life Sciences Report

Life Sciences Report Dipexium

Dipexium Pharmaceuticals Inc. is a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a potent and broad-spectrum topical antibiotic peptide for the treatment of mild and moderate skin-and skin-structure infections.

See Expert Comments here.